Tanvi is a Project Coordinator working primarily with ANSIRH’s Alternative Provision of Medication Abortion team to evaluate the impact and feasibility of expanding access to medication abortion. Tanvi is extremely passionate about improving reproductive healthcare access and outcomes for marginalized populations both domestically and internationally. Before coming to UCSF she worked at Planned Parenthood and got a firsthand look at the unnecessary, often insurmountable, obstacles patients face while trying to access care and reclaim agency over their healthcare decisions and bodies. In 2021, Tanvi received her MS in Global Health from UCSF and her thesis focused on reproductive health decision making among newly married women in India during the COVID-19 pandemic.
July 30, 2022
Kaller S, Ma M, Gurazada T, Baba F, Rafie S, Raine-Bennett T, Averbach S, Chen M, Berry E, Meckstroth KR, Grossman D. "No Big Deal”: A Qualitative Study of Pharmacists’ Perspectives on Dispensing Mifepristone for Medication Abortion. Women's Health Issues. July 2022; DOI: 10.1016/j.whi.2022.06.007.
March 10, 2021
Grossman D, Baba F, Kaller S, Biggs MA, Raifman S, Gurazada T, Rafie S, Averbach S, Meckstroth KR, Micks EA, Berry E, Raine-Bennett T, Creinin MD. Medication abortion with pharmacist dispensing of mifepristone. Obstetrics & Gynecology. March 2021; [Epub ahead of print].